Wedbush

Wedbush reduces its price target on Research in Motion (NASDAQ: RIMM) from $11.50 to $9.50 as it reiterates a Neutral rating on shares. Wedbush notes, "We continue to remain cautious on RIM and are reducing our estimates to reflect comments made by RIM's CEO in his business update. As we have...

According to a research report published this morning, Wedbush has initiated Lululemon Athletica (NASDAQ: LULU) with an Outperform rating and $90 PT. Wedbush said in the report, "We are initiating coverage of LULU with an OUTPERFORM rating and price target of $90 as we believe the company's...

According to a research report published this morning, Wedbush has upgraded Jack in the Box (NASDAQ: JACK) from Underperform to Neutral, and raised PT from $21 to $25. In the report, Wedbush said, "We are raising JACK to NEUTRAL from UNDERPERFORM. We believe JACK is positioned to benefit from a...

According to a research report published this morning, Wedbush has lowered OmniVision Technologies' (NASDAQ: OVTI) PT from $16 to $15. In the report, Wedbush said, "We maintain our NEUTRAL rating on OmniVision (OVTI) and reduce our PT to $15 from $16 ahead of its FQ4 (Apr) results set to be...

According to a research report published this morning, Wedbush has lowered Aruba Networks' (NASDAQ: ARUN) PT from $27 to $22. In the report, Wedbush said, "We think the overall macro and European issues may present near-term headwinds, but remain positive about the company's long-term growth...

According to a research report published this morning, Wedbush has decreased Summer Infant's (NASDAQ: SUMR) PT from $6 to $5. In the report, Wedbush commented, "Summer Infant reported Q1 revenue of $63 million, in line with our forecast, but slightly below consensus of $65 million. Q1 EPS of $0.07...

Wedbush lowers its price target from $27 to $23 on Neutral-rated Alere (NYSE: ALR) as FDA concerns drive tighter manufacturing methods that in turn drive higher COGS. Wedbush comments, "ALR released an 8-k late last week outlining the FDA's manufacturing concerns following a March inspection....

Wedbush lowers its rating on Republic Services (NYSE: RSG) from Outperform to Neutral and lowers its price target from $31 to $29 as volume growth and price competition provide challenges. Wedbush comments, "Downgrading to NEUTRAL as lack of volume and competitive pricing reset our margin...

According to a research report published this morning, Wedbush has lowered Echelon's (NASDAQ: ELON) PT from $7 to $5. In the report, Wedbush said, "Echelon reported 1Q12 results modestly above low expectations. The company reported revenue/EPS of $40.3m/($0.06) vs. our $40.0m/($0.10) and the...

According to a research report published this morning, Wedbush has downgraded Cost Plus (NASDAQ: CPWM) from Outperform to Neutral. In the report, Wedbush explained, "The companies have reached a definitive agreement for Bed Bath & Beyond to acquire Cost Plus for $22/share, or $495 million....